The frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with Korean Red Ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on HIV-1 evolution
- PMID: 33437166
- PMCID: PMC7790868
- DOI: 10.1016/j.jgr.2020.03.003
The frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with Korean Red Ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on HIV-1 evolution
Abstract
Background: We have reported that internal deletions in the nef, gag, and pol genes in HIV-1-infected patients are induced in those treated with Korean Red Ginseng (KRG). KRG delays the development of resistance mutations to antiretroviral drugs.
Methods: The vif-vpr genes over 26 years in 20 hemophiliacs infected with HIV-1 from a single source were sequenced to investigate whether vif-vpr genes were affected by KRG and KRG plus highly active antiretroviral therapy (ART) (hereafter called GCT) and compared the results with our previous data.
Results: A significantly higher number of in-frame small deletions were found in the vif-vpr genes of KRG-treated patients than at the baseline, in control patients, and in ART-alone patients (p < 0.001). These were significantly reduced in GCT patients (p < 0.05). In contrast, sequences harboring a premature stop codon (SC) were more significant in GCT patients (10.1%) than in KRG-alone patients, control (p < 0.01), and ART-alone patients (p = 0.078 for peripheral blood mononuclear cells). The proportion of SC in Vpr was similar to that in Vif, whereas the proportion of sequences revealing SC in the env-nef genes was significantly lower than that in the pol-vif-vpr genes (p < 0.01). The genetic distance was 1.8 times higher in the sequences harboring SC than in the sequences without SC (p < 0.001). Q135P in the vif gene is significantly associated with rapid progression to AIDS (p < 0.01).
Conclusion: Our data show that KRG might induce sΔ in the vif-vpr genes and that vif-vpr genes are similarly affected by lethal mutations.
Keywords: HIV-1; Korean Red Ginseng; Lethal mutations; Small deletion; vif-vpr genes.
© 2020 The Korean Society of Ginseng. Publishing services by Elsevier B.V.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy.J Ginseng Res. 2019 Oct;43(4):684-691. doi: 10.1016/j.jgr.2019.05.011. Epub 2019 Jun 6. J Ginseng Res. 2019. PMID: 31695572 Free PMC article.
-
Genetic defects in the nef gene are associated with Korean Red Ginseng intake: monitoring of nef sequence polymorphisms over 20 years.J Ginseng Res. 2017 Apr;41(2):144-150. doi: 10.1016/j.jgr.2016.02.005. Epub 2016 Mar 3. J Ginseng Res. 2017. PMID: 28413318 Free PMC article.
-
Effects of Korean Red Ginseng and HAART on vif Gene in 10 Long-Term Slow Progressors over 20 Years: High Frequency of Deletions and G-to-A Hypermutation.Evid Based Complement Alternat Med. 2013;2013:871648. doi: 10.1155/2013/871648. Epub 2013 Nov 14. Evid Based Complement Alternat Med. 2013. PMID: 24319487 Free PMC article.
-
Naturally occurring Vpr inhibitors from medicinal plants of Myanmar.J Nat Med. 2017 Oct;71(4):579-589. doi: 10.1007/s11418-017-1104-7. Epub 2017 Jul 5. J Nat Med. 2017. PMID: 28681118 Free PMC article. Review.
-
HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).Curr HIV Res. 2009 Mar;7(2):169-77. doi: 10.2174/157016209787581445. Curr HIV Res. 2009. PMID: 19275586 Review.
Cited by
-
Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action.J Ginseng Res. 2023 Mar;47(2):183-192. doi: 10.1016/j.jgr.2022.11.003. Epub 2022 Nov 17. J Ginseng Res. 2023. PMID: 36926608 Free PMC article. Review.
-
Clinical Applications and Therapeutic Mechanisms of Chinese Herbal Medicine Yiaikang Capsules in Treating Acquired Immune Deficiency Syndrome.Infect Drug Resist. 2025 Jul 5;18:3317-3327. doi: 10.2147/IDR.S526449. eCollection 2025. Infect Drug Resist. 2025. PMID: 40635771 Free PMC article. Review.
References
-
- Daniels R.S., Kang C., Patel D., Xiang Z., Douglas N.W., Zheng N.N., Cho H.W., Lee J.S. An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level. AIDS Res Hum Retroviruses. 2003;19:631–641. - PubMed
-
- Cho Y.K., Foley B.T., Sung H.S., Kim Y.B., Kim J.H. Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990. Vox Sang. 2007;92:113–120. - PubMed
-
- Kim B.R., Kim J.E., Sung H., Cho Y.K. Long-term follow up of HIV-1-infected Korean haemophiliacs, after infection from a common source of virus. Haemophilia. 2015;21 doi: 10.1111/hae.12527. http://www.ncbi.nlm.nih.gov/pubmed/?term=Long-term+follow+up+of+HIV-1-in... comments e1-11. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases